Enhancing Remdesivir Delivery: PJL Micelles vs SBECD Formulations
Remdesivir (REM), a nucleoside analogue that has been approved for SARS-CoV-2 treatment, is poorly soluble in water and is currently
Tag: subcutaneous administration
HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
Subcutaneous injection of an SBECD salt of ketamine
Conventional ketamine hydrochloride solutions are acidic and hyperosmotic, limiting their tolerability for subcutaneous (SC) delivery. BB106 is a novel ketamine
SQ Innovation: FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
This second-generation delivery device provides a cost-efficient alternative to in-hospital treatment. Lasix® ONYU represents the most recent FDA-approved formulation incorporating